Title: |
Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2020 edition) |
Edition: |
Updated |
Classification: |
Standard guideline |
Field: |
Diagnosis and Treatment |
Countries and regions: |
China |
Guidelines users: |
Health care workers |
Evidence classification method: |
Category 1 Based upon high-level evidence, there is a uniform consensus of the Expert Committee that the intervention is appropriate.
Category 2A Based upon lower-level evidence, there is a uniform consensus of the Expert Committee that the intervention is appropriate.
Category 2B Based upon lower-level evidence, there is a consensus of the Expert Committee that the intervention is appropriate.
Category 3 Based upon any level of evidence, there is a major disagreement of the Expert Committee that the intervention is appropriate.
|
Development unit: |
the Expert Committee of Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2020 edition) |
Registration time: |
2021-03-23 |
Registration number: |
IPGRP-2021CN058 |
Purpose of the guideline: |
For standardizing the diagnosis and management, improving the prognosis of lung cancer, and providing authoritative guidance in screening, diagnosis, pathological typing, treatment, and follow-up of lung cancer for health workers. |